HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].

Abstract
A 46-year-old woman had undergone a mastectomy in 1994, and metastases to the lung, bones and liver were detected in 1998. Brain metastases were detected later. Chemotherapy consisting of docetaxel, aclarubicin and UFT was administered, and image diagnosis revealed that CR was achieved. The chemotherapy was continued on a long-term basis, both as an inpatient and outpatient. The total administered doses have reached 2,000 mg of docetaxel and 1,000 mg of aclarubicin. The CR is being maintained as of this writing, 2 years and 4 months after the detection of the metastases. The patient's course continues to be monitored.
AuthorsH Ishihama
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 28 Issue 12 Pg. 1901-4 (Nov 2001) ISSN: 0385-0684 [Print] Japan
PMID11729484 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Drug Combinations
  • Taxoids
  • UFT(R) drug
  • Tegafur
  • Docetaxel
  • Uracil
  • Aclarubicin
  • Paclitaxel
Topics
  • Aclarubicin (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bone Neoplasms (drug therapy, secondary)
  • Brain Neoplasms (drug therapy, secondary)
  • Breast Neoplasms (drug therapy, pathology)
  • Carcinoma, Ductal, Breast (drug therapy, secondary)
  • Docetaxel
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Humans
  • Liver Neoplasms (drug therapy, secondary)
  • Lung Neoplasms (drug therapy, secondary)
  • Middle Aged
  • Paclitaxel (administration & dosage, analogs & derivatives)
  • Taxoids
  • Tegafur (administration & dosage)
  • Uracil (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: